Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Optimizing engraftment--source and dose of stem cells.

Norbert Schmitz1, John Barrett

  • 1Stem Cell Transplant Unit, Hematology Branch, National Heart, Lung and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Seminars in Hematology
|January 19, 2002
PubMed
Summary

Choosing the right stem cell source (bone marrow, peripheral blood, or cord blood) and dose significantly impacts allogeneic stem cell transplant outcomes, including engraftment, survival, and graft-versus-host disease risks.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Detection of hard electrophilic reactive metabolites formed from alicyclic amines using glutathione trapping.

Xenobiotica; the fate of foreign compounds in biological systems·2026
Same author

Bridging the climate mitigation gap with economy-wide material productivity.

Journal of industrial ecology·2026
Same author

Policymaker-led scenarios and public dialogue facilitate energy demand analysis for net-zero futures.

Nature energy·2025
Same author

The Veteran Military Occupational and Environmental Exposure Assessment Tool, Phase III Enhancements.

Military medicine·2025
Same author

NOVEL INSIGHTS IN ADVANCED THYROID CARCINOMA: FROM MECHANISMS TO TREATMENTS: Molecular insights into the origin, biology, and treatment of anaplastic thyroid carcinoma.

European thyroid journal·2025
Same author

Quantifying the energy and emissions implications of consumption redistribution in the UK through sustainable consumption corridors.

Scientific reports·2025

Area of Science:

  • Hematology
  • Immunology
  • Transplantation Science

Background:

  • Allogeneic stem cell transplantation (ASCT) outcomes are influenced by stem cell source and dose.
  • Peripheral blood (PB) and umbilical cord blood (CB) are increasingly used alongside bone marrow (BM).
  • Differences in immune cell composition and activation exist between BM, PB, and CB grafts.

Purpose of the Study:

  • To determine the impact of stem cell source and dose on ASCT outcomes.
  • To compare hematological recovery kinetics across different stem cell sources.
  • To evaluate the risks of graft-versus-host disease (GVHD) associated with various stem cell sources.

Main Methods:

  • Analysis of CD34(+) cell counts using antibody-based methods.
  • Comparison of engraftment kinetics between BM, PB, and CB transplants.

Related Experiment Videos

  • Assessment of GVHD incidence and severity based on stem cell source.

    • Main Results:

    • PB transplants show the fastest hematological recovery, while CB is the slowest.
    • PB transplants are associated with increased risks of acute and chronic GVHD compared to BM.
    • CB transplants demonstrate a low GVHD risk, even in mismatched cases.
    • Stem cell dose is an independent factor influencing engraftment, mortality, and relapse risk.

    Conclusions:

    • Stem cell source and dose are critical determinants of ASCT success.
    • Understanding these factors is essential for optimizing transplant conditions and patient outcomes.
    • Tailoring stem cell source and dose can mitigate risks like GVHD and improve engraftment.